Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria (Q44487869)

3 December 2017

Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria (English)

1 reference

3 December 2017

0 references

0 references

Ashton M

1

1 reference

3 December 2017

Nguyen DS

2

1 reference

3 December 2017

Nguyen VH

3

1 reference

3 December 2017

Gordi T

4

1 reference

3 December 2017

Trinh NH

5

1 reference

3 December 2017

Dinh XH

6

1 reference

3 December 2017

Nguyen TN

7

1 reference

3 December 2017

Le DC

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Clinical Pharmacology & Therapeutics

3 December 2017

1 reference

3 December 2017

63

1 reference

3 December 2017

4

1 reference

3 December 2017

482-493

1 reference

Quinine disposition during malaria and during induced fever

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Possible isozyme-specific effects of experimental malaria infection with Plasmodium berghei on cytochrome P450 activity in rat liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

The binding of the antimalarial arteether to human plasma proteins in-vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Qinghaosu (artemisinin): an antimalarial drug from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Treatment of Malaria in Vietnam with Oral Artemisinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

A randomized comparative study of artemisinine (qinghaosu) suppositories and oral quinine in acute falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Comparative effectiveness of artemisinin suppositories and oral quinine in children with acute falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Pharmacokinetics of mefloquine, when given alone and in combination with artemether, in patients with uncomplicated falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

Single-dose, comparative study of venous, capillary and salivary artemisinin concentrations in healthy, male adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990044-3

10.1016/S0009-9236(98)90044-3

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference